Navigation Links
Medisafe 1 Technologies in Advanced Negotiations for $7MM Perpetual License Sale
Date:8/30/2012

JERUSALEM, August 30, 2012 /PRNewswire/ --

Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company is in advanced negotiations to enter into a non-exclusive perpetual license agreement to transfer rights for the full commercialization, marketing and distribution of its patented medicinal locking mechanism and bar-code matching system.

Terms of the sale include a one-time payment of $7MM.  The perpetual license agreement is anticipated to be signed within 60 days, pending the results of a due diligence study by the intended buyer.

The patented technology physically prevents medication administration errors in hospitals.  The device includes a syringe locking mechanism that works in concert with a bar-code reader and database system.  

The device electronically confirms whether the syringe held by a medical practitioner contains the correct medication and dosage that has been prescribed to a particular patient, before allowing that medication to be physically administered.

"We hope to soon announce the closing of the perpetual license sale, which will enable the wider distribution of our technology, and to fulfill the principles of our business plan," said Jacob Elhadad, CEO of Medisafe 1 Technologies Corp. "The sale, if completed will infuse Medisafe with much needed capital to further develop and market our proprietary, life-saving devices."


About Medisafe 1 Technologies

Medisafe 1 Technologies seeks to effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle.  Medisafe's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient.

Forward-Looking Statements

This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of Medisafe 1 Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated.  Medisafe 1 Technologies Corp. public filings may be viewed at http://www.sec.gov.

Contact: Jacob Elhadad CEO, +972-524440000, Jacob.elhadad10@gmail.com


'/>"/>
SOURCE Medisafe 1 Technologies Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Medisafe 1 Technologies Corp has of Today Acquired 3,100,000 Shares and Continues to Acquire Shares Under its $1MM Stock Repurchase Program of 10MM Shares up to 10 Cents a Share to Facilitate its On-going Acquisitions Activity Plan
2. Global E-Clinical Trial Technologies Industry
3. BioSpecifics Technologies Corp. To Present at Stifel Nicolaus Weisel Healthcare Conference 2012
4. Antifungal Drugs: Technologies and Global Markets
5. Cleveland Clinics 2012 Medical Innovation Summit Highlights Orthopaedic Technologies
6. Breast Cancer Diagnostic and Drug Technologies: Global Markets
7. ARAMARK Healthcare Technologies Taps Robert Steele to Lead ReMedPar
8. Montmed to Participate in 2013 Advanced Technologies and Treatments for Diabetes Conference
9. U.S. Navy Awards Multi-Million Dollar Contract to Innovation for Pharmacy Automation Technologies
10. Technologies Impacting the Future of Healthcare
11. ECRI Institute Helps Hospitals Design Spaces for Current and Future Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)...   Mostyn Law and Gulf Coast Regional Blood Center ... . The Mostyn Law family has had 3 members ... why Mostyn Law is partnering with Gulf Coast Regional ... appreciation. Blood supplies are running low. Gulf Coast Regional ... needs in August. That is why the blood center reached out ...
(Date:8/14/2017)... TIKVAH, Israel , Aug. 15, 2017 ... developer of adult stem cell technologies for neurodegenerative diseases, ... 30, 2017. "We ... pivotal Phase 3 trial to investigate NurOwn ® ... Chief Executive Officer of BrainStorm. "We have agreements with ...
(Date:8/7/2017)... Md. , Aug. 7, 2017 ... healthcare member acquisition, retention, and engagement, announced the ... of Strategy and Product Development, effective as of ... consulting and technology implementation strategy for our clients. ... of experience in consulting and business analytics within ...
Breaking Medicine Technology:
(Date:8/18/2017)... ... 2017 , ... MLM Insurance Group, a Miami area provider ... is working to support the Take Stock In Children Foundation during a regional ... The Take Stock In Children Foundation (TSC) offers guidance and assistance to low ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... financial planning firm that serves residential and commercial clients in the greater Houston ... to raise community support for the fight against cancer. , Founded by Tony ...
(Date:8/18/2017)... , ... August 18, 2017 , ... “Emotions are sacred, ... Founder of St. Louis-based positive education company Generation Mindful. To help change the mindset ... learn social and emotional skills, she created the Time-In Toolkit, which launched on Kickstarter ...
(Date:8/18/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has ... teachings pertaining to the mother of the Savior whom the world calls “Mother Mary”. Yisrayl ... of the role of this historical woman. , “The world bows, kisses the feet ...
(Date:8/18/2017)... CARMEL, IN (PRWEB) , ... August 18, 2017 , ... ... 36th annual list, the most prestigious ranking of the nation's fastest-growing private companies. This ... in the exclusive Inc. 5000 ranking . This year’s ranking reflects ASH’s 76 ...
Breaking Medicine News(10 mins):